This page shows the latest Sean Harper news and features for those working in and with pharma, biotech and healthcare.
Adds to trend in senior leaders. Amgen’s long-serving head of R&D Sean Harper (pictured) is retiring from his position and is looking for “opportunities in the early-stage ... Harper will be succeeded by Dave Reese, who has been with Amgen since 2005
Amgen R&D chief Sean Harper said: “We are encouraged by these new findings, which add to the growing body of clinical evidence supporting potential use of Aimovig across a broad
Sean Harper, executive vice president of research and development at Amgen, said: “The EC’s approval of Mvasi marks a significant milestone for both Amgen and the oncology community, providing a
Sean Harper, executive vice president of research and development, Amgen, said: “Kyprolis has been demonstrated to be the most effective proteosome inhibitor available to patients with multiple myeloma.
s head of R&D Sean Harper.
Sean Harper, executive vice president of research and development at Amgen, said: "The approval of our first biosimilar by the European Commission is a major milestone not just for Amgen as
More from news
Approximately 1 fully matching, plus 47 partially matching documents found.
Elliott brings a wealth of development and leadership experience to his new role at Amgen,” said Dr Sean Harper, executive VP of R&D at Amgen.
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...